Skip to main content
Log in

Soluble circulating cell adhesion molecules in haemolytic uraemic syndrome

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Plasma concentrations of soluble vascular cell adhesion molecule-1 (sVCAM-1), E-selectin (sE-selectin) and intercellular adhesion molecule-1 (sICAM-1) were measured by enzyme-linked immunosorbent assay in four groups of children. Group 1 consisted of 20 patients with acute diarrhoea-associated haemolytic uraemic syndrome (D+HUS), the aetiology of HUS being verocytotoxin-producingEscherichia coli infection in each case. Controls consisted of 11 patients who had previously had D+HUS (group 2), 12 with chronic renal failure (group 3) and 8 healthy controls (group 4). When compared with healthy controls, the acute D+HUS group had higher sVCAM-1 (median 1,875 ng/ml, range 1,200–6,450 ng/ml vs. 1,200 ng/ml, range 975–2,125 ng/ml), von Willebrand factor antigen, (1.9 U/ml, range 0.85–5.1 U/ml vs. 0.55 U/ml, range 0.3–1.57 U/ml), white cell count (WBC, 14.5×109/l, range 7.8–43.1 109/l vs. 8.9 109/l, range 5.7–10.8 109/l) and neutrophil count (PMN, 10.1×109/l, range 4.3–26.5 109/l vs. 4.3 109/l, range 3.7–6.6 109/l), allP<0.005, and sICAM-1 was reduced (230 ng/ml, range 130–340 ng/ml vs. 400 ng/ml, range 260–690 ng/ml),P<0.05. Within the acute D+HUS group there was a significant correlation between sICAM-1 and PMN (r=0.56,P<0.01). There was no correlation between any adhesion molecule and plasma creatinine or von Willebrand factor. Comparing the acute HUS group with children with chronic renal failure, WBC (P<0.001), PMN (P<0.01) and sVCAM-1 (P<0.01) were significantly elevated, but there was no difference between the von Willebrand factor (P=0.08) or the sICAM-1 (P>0.1). sVCAM-1 is elevated and sICAM-1 decreased in acute D+HUS. This pattern of altered adhesion molecule concentration is unlike that in adults with vasculitis and suggests that different endothelial regulatory factors are at play.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Habib R, Levy M, Gagnadoux MF, Broyer M (1982) Prognosis of the hemolytic uremic syndrome in children. Adv Nephrol 11: 99–128

    Google Scholar 

  2. Milford DV, Staten J, MacGreggor I, Dawes J, Taylor CM, Hill FG (1991) Prognostic markers in diarrhoea-associated haemolytic-uraemic syndrome: initial neutrophil count, human neutrophil elastase and von Willebrand factor antigen. Nephrol Dial Transplant 6:232–237

    PubMed  Google Scholar 

  3. Walters MD, Matthei I, Kay R, Dillon MJ, Barratt TM (1989) The polymorphonuclear leucocyte count in childhood haemolytic uraemic syndrome. Pediatr Nephrol 3:130–134

    PubMed  Google Scholar 

  4. Coad NAG, Marshall T, Rowe B, Taylor CM (1991) Changes in the postenteropathic form of the hemolytic uremic syndrome in children. Clin Nephrol 35:10–16

    PubMed  Google Scholar 

  5. Fitzpatrick MM, Shah V, Filler G, Dillon MJ, Barratt TM (1992) Neutrophil activation in the haemolytic uraemic syndrome: free and complexed elastase in plasma. Pediatr Nephrol 6:50–53

    PubMed  Google Scholar 

  6. Fitzpatrick MM, Shah V, Trompeter RS, Dillon MJ, Barratt TM (1992) Interleukin-8 and polymorphoneutrophil leucocyte activation in hemolytic uremic syndrome of childhood. Kidney Int 42: 951–956

    PubMed  Google Scholar 

  7. Taylor CM (1992) Neutrophils in haemolytic uraemic syndrome: are they markers or participants in the pathogenesis. Pediatr Nephrol 6:c43

    Google Scholar 

  8. Springer TA (1990) Adhesion receptors of the immune system. Nature 342:425–434

    Google Scholar 

  9. Rice GE, Munro MJ, Corless C, Bevilacqua (1991) Vascular and nonvascular expression of INCAM-110. Am J Pathol 138: 385–393

    PubMed  Google Scholar 

  10. Garner CM, Richards GM, Adu D, Pall AA, Taylor CM, Richards NT (1994) ICAM-1 and VCAM-1 expression and function by human glomerular epithelial cells. Clin Exp Immunol 95: 322–326

    PubMed  Google Scholar 

  11. Cotran RS, Gimbrone MA, Bevilacqua MP, Mendrick DL, Pober JS (1986) Induction and detection of a human endothelial activation antigen in vivo. J Exp Med 164:661–666

    PubMed  Google Scholar 

  12. Adams DH, Mainolfi E, Elias E, Neuberger JM, Rothlein R (1992) Detection of circulating ICAM-1 after liver transplantation: evidence for local release within the liver during liver allograft rejection. Transplantation 55:83–87

    Google Scholar 

  13. Ballantyne C, Mainolfi E, Young JB, Windsor NT, Cocanougher B, Lawrence EC, Anderson DC, Rothlein R (1991) Prognostic value of increased levels of circulating intercellular adhesion molecule-1 after heart transplant. Clin Res 39:285a

    Google Scholar 

  14. Adams DH, Mainolfi E, Burra P, Neuberger JM, Ayres R, Elias E, Rothlein R (1992) Detection of circulating intercellular adhesion molecule-1 in chronic liver diseases. Hepatology 16:810–814

    PubMed  Google Scholar 

  15. Gearing AJH, Hemingway I, Pigott R, Hughes J, Rees AJ, Cashman SJ (1992) Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1 and VCAM-1: pathological significance. Ann NY Acad Sci 667:324–331

    PubMed  Google Scholar 

  16. Harning R, Mainolfi E, Bystryn JC, Henn M, Merluzzi VJ, Rothlein R (1991) Serum levels of circulating ICAM-1 in human malignant melanoma. Cancer Res 51:5003–5005

    PubMed  Google Scholar 

  17. Pall AA, Adu D, Drayson M, Taylor CM, Richards NT, Michael J (1994) Circulating soluble adhesion molecules in systemic vasculitis. Nephrol Dial Transplant 9:770–774

    PubMed  Google Scholar 

  18. Short PE, Williams CE, Picken AM, Hill FG (1982) Factor VIII-related antigen: an improved enzyme immunoassay. Med Lab Sci 39:351–355

    PubMed  Google Scholar 

  19. Pober JS, Cotran RS (1990) Cytokines and endothelial cell biology. Physiol Rev 70:427–451

    PubMed  Google Scholar 

  20. Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD (1991) A form of circulating ICAM-1 in human serum. J Immunol 147: 3788–3793

    PubMed  Google Scholar 

  21. Newman W, Dawson Beall L, Carson CW, Hunder GG, Graben N, Randhawa ZI, Gopal TV, Wiener-Kronish J, Matthay MA (1993) Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. J Immunol 150:644–654

    PubMed  Google Scholar 

  22. Wellicome SM, Kapachi P, Mason JC, Lebranchu Y, Yarwood H, Haskard DO (1993) Detection of a circulating form of vascular cell adhesion molecule-1: raised levels in rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Immunol 92:412–418

    PubMed  Google Scholar 

  23. Gearing AJH, Newman W (1993) Circulating adhesion molecules in disease. Immunol Today 14:506–512

    PubMed  Google Scholar 

  24. Katayama M, Handa M, Araki Y, Ambo H, Kawai Y, Watanabek K, Ikeda Y (1993) Soluble P-selectin is present in normal circulation and its plasma level is elevated in patients with thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome. Br J Haematol 84:702–710

    PubMed  Google Scholar 

  25. Tipping PG, Huang XR, Berndt MC, Holdsworth SR (1994) A role for P selectin in complement-independent netrophil-mediated glomerular injury. Kidney Int 46:79–88

    PubMed  Google Scholar 

  26. Inward CD, Williams J, Chant I, Crocker J, Milford DV, Rose PE, Taylor CM. (1995) Verocytotoxin-1 induces apoptosis in vero cells. J Infect 30:213–218

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Inward, C.D., Pall, A.A., Adu, D. et al. Soluble circulating cell adhesion molecules in haemolytic uraemic syndrome. Pediatr Nephrol 9, 574–578 (1995). https://doi.org/10.1007/BF00860938

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00860938

Key words

Navigation